Empagliflozin Win in EMPEROR-Preserved HF, but Renal Outcomes Puzzle Empagliflozin Win in EMPEROR-Preserved HF, but Renal Outcomes Puzzle

The EMPEROR-Preserved trial of empagliflozin to treat patients with HFpEF comes with a lot more outcome analyses that also deserve attention, most notably some puzzling renal findings.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news